2024 Surgery Grand Rounds | Minimally Invasive Esophagectomy (MIE): Less is More
Gastric cancer occurs at a higher rate in minority groups and its frequency is increasing. Surgeons in the U.S. are adapting their practices to include more advanced robotic techniques to improve patient outcomes. Due to low prevalence of the disease in certain parts of the U.S., the surgical technique is less widely embraced.
There is a need to address and familiarize the minimally invasive surgerry (MIS) approach of esophagectomy/gastrectomy to a wide surgical audience. MIS approach is not rountinely performed by all U.S. surgeons due to the advanced technique required. MIS approach has been associated with superior patient outcomes, therefore, providing clinicians with updates on this approach will gear in the right direction toward ideal practice, resulting in low readmission rates, and optimal survival to fast track protocols.
Surgeons within the Department of Surgery at City of Hope.
- Demonstrate surgical principles and novel techniques for minimally invasive esophagectomy (MIE).
- Outline the important findings of pre and intraoperative nutrition for esophageal cancer patients.
- Determine if high volume centers are preferable for esophageal cancer surgery.
- Discuss resource utilization for MIE.
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Jeffrey B. Velotta, MD, FACS Thoracic Surgeon, Kaiser Permanente Northern California; Clinical Professor, Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine; Clinical Assistant Professor, Department of Surgery, UCSF School of Medicine
Presenter: Dr. Velotta has indicated that there are no relevant financial relationships.
Planner: Kelly Mahuron, MD has indicated that there are no relevant financial relationships. Yuman Fong, MD has indicated the following relevant financial relationships: Consultant for Eureka, Medtronics, Theromics, Vergent Biosciences, and XDemics; Stock/Shareholder of Imugene, Iovance, and XDemics; Other financial/material interests (Royalties) in Imugene, and XDemics.
The educational content has been peer-reviewed, an attestation on file and no conflicts were noted.
CME Committee/Reviewer no relevant financial relationships: Daneng Li, MD
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2024 Surgery Grand Rounds | Minimally Invasive Esophagectomy (MIE): Less is More for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Attendance